Open AccessA young adult with multisystem inflammatory syndrome (MIS-A) following COVID-19 infection: A case report
Author(s) -
Subhajit Sen,
Suresh Ramasubban,
Chadrashish Chakravarty,
Lawni Goswami,
Debasis Rout,
Anupam Mohapatra
Publication year - 2022
Publication title -
indian journal of immunology and respiratory medicine
Language(s) - English
Resource type - Journals
ISSN - 2456-012X
DOI - 10.18231/j.ijirm.2022.008
Subject(s) - medicine , rash , toxic shock syndrome , myalgia , covid-19 , methylprednisolone , immunology , throat , antibody , surgery , staphylococcus aureus , disease , biology , bacteria , infectious disease (medical specialty) , genetics
Recent reports have described a secondary Multi system Inammatory Syndrome in adult (MIS-A)and its temporal association with COVID-19 infection. Here, we report the case of a 25-year-old male who presented with shock and multi organ failure. Three-week prior to present admission he developed an Influenza like illness, secondary to SARS-CoV2 infection as detected by a reverse-transcription polymerase chain reaction (RT-PCR). Three weeks later, patient had recurrence of fever associated with throat pain, neck swelling, and a rash followed by shock and multiorgan failure. Laboratory work revealed elevated inflammatory markers. His throat swab for SARS-CoV-2 by RT-PCR was negative and SARS-CoV-2 IgG antibody was reactive.In view of presentation like multi-inflammatory syndrome in children (MIS-C) a probable diagnosis of MIS-A was made. He was successfully treated with intravenous Immunoglobulin and pulse dose Methylprednisolone. This case highlights the need to remain vigilant for multisystem inammatory syndromes in the COVID-19 affected patients.[